Spencer David M. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Spencer David M.
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-02+18,000→ 18,000 totalExercise: $9.23Exp: 2028-01-01→ Common Stock (18,000 underlying) - Award
Restricted Stock Units
2018-01-02+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 2, 2019.